Publications by authors named "Bakr A Albrakati"
Article Synopsis
- COVID-19 has prompted rapid vaccine development, including the Oxford-AstraZeneca Vaccine (AZD1222), to combat health impacts from the virus.
- A case study highlights a 37-year-old woman who developed pityriasis rosea (PR) after receiving her second dose of the AZD1222 vaccine, showing immune response side effects tied to vaccination.
- Interestingly, while some literature associates PR with the Pfizer BioNTech vaccine, this patient had no adverse effects after subsequently receiving a booster of the same Pfizer vaccine.
Article Synopsis
- - Pityriasis rubra pilaris (PRP) is a rare skin condition with six types; Type 5 is known as atypical juvenile PRP, which affects younger individuals.
- - A 17-year-old boy, experiencing itchy skin lesions since age seven, was diagnosed with Type 5 PRP after skin examination and a biopsy showed specific patterns in the skin.
- - The patient was treated with isotretinoin (20 mg twice daily) and scheduled for regular follow-ups to monitor his condition.
